Oncology Hallmark Coverage-Gap Atlas

A subscription intelligence product that maps every approved and late-pipeline oncology drug to the hallmark, enabling characteristic, or systemic dimension it targets — showing pharma strategy and BD teams which hallmarks are crowded, which are white space, and which co-targeting pairs remain unexploited.